Moreover, DVL1 and DVL3 expression is increased in metastatic tumors compared to primary NSCLC, and DVL1 expression positively correlates with β-catenin expression metastatic NSCLC [91]. Here, DVL3 is linked to non-small cell lung carcinoma.